Roix; Jeffrey James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Roix; Jeffrey James.The latest application filed is for "cancer treatments using combinations of cdk and erk inhibitors".

Company Profile

2.7.14

Roix; Jeffrey James - Boston US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cancer Treatments Using Combinations Of Cdk And Erk Inhibitors App 20210393637 - Saha; Saurabh ; et al.	2021-12-23
Cancer treatments using combinations of CDK and ERK inhibitors Grant 11,135,225 - Saha , et al. October 5, 2	2021-10-05
Cancer treatments using combinations of CDK and ERK inhibitors Grant 11,013,743 - Saha , et al. May 25, 2	2021-05-25
Cancer treatments using combinations of type 2 MEK and ERK inhibitors Grant 11,007,184 - Saha , et al. May 18, 2	2021-05-18
Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors Grant 11,007,183 - Saha , et al. May 18, 2	2021-05-18
Methods And Compositions For Treating Non-erk Mapk Pathway Inhibitor-resistant Cancers App 20210038587 - Saha; Saurabh ; et al.	2021-02-11
Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers Grant 10,881,646 - Saha , et al. January 5, 2	2021-01-05
Cancer Treatments Using Combinations Of Cdk And Erk Inhibitors App 20200297730 - Saha; Saurabh ; et al.	2020-09-24
Cancer treatment using combinations of ERK and RAF inhibitors Grant 10,668,055 - Saha , et al.	2020-06-02
Methods And Compositions For Treating Non-erk Mapk Pathway Inhibitor-resistant Cancers App 20180104228 - Saha; Saurabh ; et al.	2018-04-19
Compositions and methods of treating gliomas Grant 9,757,424 - Halse , et al. September 12, 2	2017-09-12
Cancer Treatments Using Combinations Of Type 2 Mek And Erk Inhibitors App 20160367539 - Saha; Saurabh ; et al.	2016-12-22
Cancer Treatments Using Combinations Of Pi3k/akt Pathway And Erk Inhibitors App 20160317517 - Saha; Saurabh ; et al.	2016-11-03
Cancer Treatments Using Combinations Of Cdk And Erk Inhibitors App 20160317538 - Saha; Saurabh ; et al.	2016-11-03
Methods And Compositions For Treating Non-erk Mapk Pathway Inhibitor-resistant Cancers App 20160317519 - Saha; Saurabh ; et al.	2016-11-03
Cancer Treatments Using Combinations Of Mek Type 1 And Erk Inhibitors App 20160310477 - Saha; Saurabh ; et al.	2016-10-27
Cancer Treatment Using Combinations Of Erk And Raf Inhibitors App 20160310476 - Saha; Saurabh ; et al.	2016-10-27
Bispecific Antibodies App 20160145355 - SAHA; Saurabh ; et al.	2016-05-26
Compositions And Methods For Treating Metabolic Disorders App 20150018360 - Halse; Reza ; et al.	2015-01-15
Compositions And Methods Of Treating Gliomas App 20140235556 - Halse; Reza ; et al.	2014-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.